Dexamethasone Dosing for Extubation

Optimal Dosing Regimen

The American College of Cardiology recommends administering dexamethasone 0.5-1.0 mg/kg (maximum 8-10 mg per dose) every 6 hours, starting 12-24 hours before planned extubation, for a total of 4 doses, to prevent post-extubation airway obstruction in adults at high risk 1
For pediatric patients, a dose of 0.5 mg/kg per dose (maximum 8-10 mg) every 6-8 hours is recommended, starting 12-24 hours before extubation 3
In neonates with bronchopulmonary dysplasia (BPD), low-dose dexamethasone (<0.2 mg/kg per day) may be used to facilitate extubation, while hydrocortisone 1 mg/kg per day may be a safer alternative in the first 2 weeks of life 4

The optimal timing for dexamethasone administration is 12-24 hours before planned extubation, which provides maximum benefit in preventing post-extubation airway obstruction 1, 2, 3
Early administration (>12 hours before extubation) is significantly more effective than late administration (<6 hours) in preventing upper airway obstruction, with a significant reduction in incidence (OR 0.40, 95% CI 0.21-0.73) 1, 3

Patients with a cuff leak pressure >25 cmH₂O, prolonged intubation (>48-72 hours), traumatic intubation or multiple intubation attempts, and female gender are at high risk of post-extubation airway obstruction and may benefit from prophylactic dexamethasone 1, 3

If laryngeal edema develops despite prophylaxis, continuing dexamethasone every 6 hours for 12-24 hours maximum, adding nebulized epinephrine 1 mg for rapid relief, and considering ENT consultation if laryngeal anomaly is suspected may be beneficial 1, 2

The evidence demonstrates that early initiation (>12 hours before extubation) is more important than the specific dose used in preventing upper airway obstruction, with high-dose early use (HE) and low-dose early use (LE) regimens having the highest probability of being top-ranked 1, 3
While dexamethasone reduces upper airway obstruction, it does not significantly reduce overall extubation failure rates (OR 0.55, 95% CI 0.21-1.46) 1, 3